Indication
STEMI
14 clinical trials
17 products
2 drugs
Product
FDY-5301Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intravenous FDY 5301 in Patients With an Anterior ST-Elevation Myocardial InfarctionStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
The Safety and Long-Term Clinical Benefit of PCSK9i in Addition to Statin Therapy in Patients With ST-Segment Elevation Myocardial Infarction. A Randomized, Open Label Study.Status: Not yet recruiting, Estimated PCD: 2024-10-30
Product
EvolocumabClinical trial
A Randomised Trial to Evaluate the Efficacy of Low-dose Intracoronary Tenecteplase in ST-Elevation Myocardial Infarction (STEMI) Patients With High Microvascular Resistance Post-percutaneous Coronary Intervention (PCI).Status: Recruiting, Estimated PCD: 2024-12-31
Product
TenecteplaseClinical trial
Evaluation of Long-term Lipid-lowering Therapy on Myocardial Electrical Heterogeneity, Myocardial Deformation, Arterial Stiffness and Quality of Life in Patients With Primary STEMI/NSTEMI With Coronavirus Infection COVID-19Status: Active (not recruiting), Estimated PCD: 2024-11-01
Product
AtorvastatinProduct
Atorvastatin-EzetimibeClinical trial
Empagliflozin for Reducing the Risk of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial InfarctionStatus: Not yet recruiting, Estimated PCD: 2025-01-15
Product
EmpagliflozinProduct
PlaceboClinical trial
Anticoagulant Regimens Given to Achieve Thrombus Regression and Reduce Clinical Outcomes Among Patients With Non Device-related Intra-cardiac Thrombus: a Randomized Assessment Under Direct Oral Anticoagulant and Vitamin-k Antagonist TherapyStatus: Recruiting, Estimated PCD: 2025-04-01
Product
Vitamin K antagonistProduct
Direct Oral AnticoagulantClinical trial
Effect of Diagnostic Echocardiogram on Microvascular Recovery Following Acute STEMIStatus: Completed, Estimated PCD: 2023-03-03
Product
MicrobubblesClinical trial
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial InfarctionStatus: Recruiting, Estimated PCD: 2026-01-09
Product
Dapagliflozin propanediolClinical trial
Effectiveness and Safety of Early Administration of Heparin at First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: a Multicenter, Prospective, Randomized, Controlled StudyStatus: Active (not recruiting), Estimated PCD: 2023-08-20
Product
Heparin SodiumClinical trial
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome: the Randomized, Multicenter, Double-blind ELECTRA RCT StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Product
TicagrelorDrug
AspirinClinical trial
Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI)Status: Recruiting, Estimated PCD: 2023-12-29
Product
ColchicineClinical trial
Effect of rhBNP on Coronary Microcirculation in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCIStatus: Not yet recruiting, Estimated PCD: 2024-12-20
Product
B-type natriuretic peptideProduct
Oral PyridoxineClinical trial
Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI PatientsStatus: Recruiting, Estimated PCD: 2025-03-15
Drug
DapagliflozinClinical trial
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction: A Single-center，Randomized,Open-label TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Product
evolocumab